Search

To assess HIV/sexually transmitted infection (STI) prevalence and associated risk factors among miners in Yunnan, China.A cross-sectional study was conducted among 1798 miners in 2 townships of Gejiu City, Yunnan, from March to May 2006. Standardized interviewer-administered questionnaires were completed and specimens collected for HIV/STI testing.The prevalence of HIV, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis, herpes simplex virus-2, and any STIs among all miners was 0.7%, 4.8%, 0.8%, 1.8%, 9.6%, and 14.9%, respectively. One fifth of miners reported patronizing female sex workers (FSWs) at least once, and of these, 72% never used a condom with a FSW. Miners who visited FSWs had a higher prevalence of HIV (1.8% vs. 0.5%) and any STI (23.2% vs. 4.3%), including C. trachomatis (6.9% vs. 4.3%), N. gonorrhoeae (2.1% vs. 0.5%), and herpes simplex virus-2 (14.9% vs. 8.4%), and higher rates of illegal drug use compared with miners who visited no FSWs.High prevalence of HIV/STIs among miners in Gejiu warrants special attention to this population, and vigorous interventions should address both sexual and drug use-related risk.

Effective tuberculosis (TB) control in HIV-prevalent settings is hindered by absence of accurate, rapid TB diagnostic tests. We evaluated the accuracy of a urine lipoarabinomannan (LAM) test for TB diagnosis in South Africa.Hospitalized adults with signs and/or symptoms of active TB were enrolled. Sputum smear microscopy and mycobacterial culture, mycobacterial blood culture, and HIV testing were performed. A spot urine specimen was tested for LAM.Four hundred ninety nine participants were enrolled; 422 (84.6%) were HIV infected. In microbiologically confirmed TB patients, the LAM test was positive in 114 of 193 [sensitivity 59%, (95% confidence interval: 52 to 66)], including 112 of 167 [67% (59 to 74)] who were HIV infected. Among individuals classified as "not TB", the LAM test was negative in 117 of 122 [specificity 96% (91 to 99)], including 83 of 88 [94% (87 to 98)] who were HIV infected. In confirmed TB patients, the LAM test was more sensitive than sputum smear microscopy (42%, 82 of 193, P0.001) and detected 56% (62 of 111) of those who were sputum smear negative. HIV infection [adjusted odds ratio (AOR 13.4)], mycobacteremia (AOR 3.21), and positive sputum smear (AOR 2.42) were risk factors for a positive LAM test.The urine LAM test detected a subset of HIV-infected patients with severe TB in whom sputum smear microscopy had suboptimal sensitivity. The combination of urine LAM testing and sputum smear microscopy is attractive for use in settings with high HIV burden.